Fusion of genomic and pathological data for breast cancer detection using BCDNN

Read full text
Authors: Anas Bilal, Waeal J. Obidallah, Sobia Wassan, Mubarak Albathan, Riyad Almakki, Zeyad Alshaikh, Muhammad Shafiq
Cited by: 1
References: 34

Abstract

Background of study: Breast cancer is one of the leading causes of mortality among women worldwide. Early and accurate detection is crucial for improving treatment outcomes and survival rates. Recent advancements in Deep Learning (DL), Artificial and Intelligence (AI), have shown promising results in medical image analysis and cancer prediction. Purpose: This study aims to develop and evaluate a BCDNN model that classifies tumors as benign or malignant using genomic and histopathological data. The research focuses on improving diagnostic accuracy through AI-driven methods. Method: The proposed BCDNN model was implemented in MATLAB R2016. A publicly available breast cancer dataset from Kaggle was used, encompassing both genomic and pathological features. The dataset was pre-processed and feature selected before training the BCDNN with optimized hyperparameters. Result: The proposed model achieved a mean classification accuracy of 93.84% during cross-validation, demonstrating stable, reliable performance in distinctive between benign and malignant cases. Conclusion: The BCDNN model shows significant promise in supporting clinical decision-making for breast cancer diagnosis. Future work may enhance model generalizability and explore integration with real-time diagnostic systems, contributing to better health outcomes for women globally. The code for this study is available on GitHub.

Fields of Study & Subjects

AI in cancer detection Digital Imaging for Blood Diseases Brain Tumor Detection and Classification

Publication details

Journal / source
Frontiers in Medicine
Publisher
Frontiers Media SA
Volume
13
Pages
1726223–1726223
Publication date
18 February 2026
Language
EN